Henderson Molly 4
4 · Phathom Pharmaceuticals, Inc. · Filed Dec 20, 2024
Insider Transaction Report
Form 4
Henderson Molly
CFO and CBO
Transactions
- Sale
Common Stock
2024-12-19$8.00/sh−1,291$10,328→ 98,156 total
Holdings
- 1,911.27(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.